Advances in economic analysis and screening strategies for hepatitis C screening
DOI:10.3969/j.issn.1001-5256.2020.10.032
- VernacularTitle:丙型肝炎筛查的经济学分析及策略
- Author:
Tianqi REN
1
;
Lamei LI
;
Qianqian YANG
;
Xia ZHANG
;
Liting LUO
;
Junqi NIU
Author Information
1. Department of Hepatology, The First Hospital of Jilin University, Changchun 130021, China
- Publication Type:Research Article
- Keywords:
hepatitis C;
costs and cost analysis;
screening;
early diagnosis
- From:
Journal of Clinical Hepatology
2020;36(10):2305-2309
- CountryChina
- Language:Chinese
-
Abstract:
With the appearance of direct-acting antivirals (DAAs), breakthroughs have been achieved in the antiviral therapy for hepatitis C and hepatitis C patients can be cured completely. Due to the insidious onset of hepatitis C, most patients do not know their own conditions, and thus expanding diagnosis and treatment through screening is the key to the elimination of hepatitis C. However, hepatitis C virus is distributed widely and unevenly in the world, which results in difficulties in the screening and diagnosis of hepatitis C. This article introduces the current economic research on hepatitis C screening, analyzes the factors affecting the cost-effectiveness of hepatitis C screening, and shares the strategies and advances for hepatitis C elimination in other countries, so as to provide a reference for eliminating hepatitis C in China.
